期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

缺血修饰白蛋白在急性心肌缺血中的诊断价值及研究进展

Advances of research on diagnostic value of ischemia modified albumin in acute myocardial ischemia
下载PDF
导出
摘要 急性冠状动脉综合征是临床常见的造成急性心肌缺血性死亡的主要原因,对其进行早期诊断和治疗可以改善患者预后。大量的临床研究证实,近年发现的缺血修饰白蛋白是对心肌缺血敏感,并可早期检测出的生化标志物,对急性心肌缺血鉴别诊断具有较高的灵敏性,对危险分层及预后也有较高价值。本文对缺血修饰白蛋白在急性心肌缺血中的诊断价值及研究进展进行综述。 Acute coronary syndrome（ACS） is one of the major causes of death caused by acute myocardial ischemia. Early diagnosis and treatment can improve prognosis of the patients. A large number of clinical researches have proved that isehemia modified albumin （IMA）,which has been found lately,is a biochemical marker of ischemia and can be detected sensitively and early. IMA has great sensitivity in the early diagnosis and identification of acute myoeardial ischemia and has high value for the danger stratification and prognosis. The diagnostic value and advances of research on IMA in ACS are reviewed in this paper.
作者 何旋芳 卞金陵
机构地区 第二军医大学长海医院预防保健科 桂林空军学院卫生科
出处 《药学服务与研究》 CAS CSCD 2008年第6期413-416,共4页 Pharmaceutical Care and Research
关键词 缺血修饰白蛋白 急性心肌缺血 诊断 综述 ischemia modified albumin acute myocardial ischemia diagnosis review
分类号 R540.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献26

  • 1The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the re definition of myocardial infarction [J]. J Am Coll Cardiol, 2000,36(3) :959-969.
  • 2Lippi G, Montagnana M, Salvagno G L, et al. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes[J]. Can J Emerg Med, 2006,8 (1): 27-31.
  • 3Sinha M K,Roy D,Gaze D C,et al. Role of "ischemia modified albumin",a new biochemical marker of myocardial ischemia,in the early diagnosis of acute coronary syndromes[J]. Emerg Med J,2004,21(1) :29-34.
  • 4Bar Or D, Lau E, Winkler J V. A novel assay for cobaltalbumin binding and its potential as a marker for myocardial isehemia-a preliminary report[J]. J Emerg Med, 2000, 19 (4) :311-315.
  • 5Sadler P J,Tueker A,Viles J H. Involvement of a lysine residue in the N-terminal Ni^2+ and Cu^2+ binding site of serum albumins. Comparison with Co^2+ , Cd^2+ and Al^3+ [J]. Eur J Biochem, 1994,220(1):193-200.
  • 6Chan B, Dodsworth N, Woodrow J, et al. Site-specific N-terminal auto-degradation of human serum albumin[J]. Eur J Biochem,1995,227(1-2) :524-528.
  • 7Wu A H,Morris D L, Fletcher D R, et al. Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin Ⅰ for the early detection of acute myocardial infarction[J]. Cardiovase Toxicol, 2001,1 (2) : 147-151.
  • 8Worster A,Devereaux P J, Heels-Ansdell D,et al. Capability of isebemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome[J]. CMAJ,2005,172(13) : 1685-1690.
  • 9Bar-Or D, Winkler J V, Vanbenthuysen K, et al. Reduced albumin cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to ereatine kinase-MB, myoglobin, and troponin Ⅰ [J].Am Heart J,2001,141(6):985-991.
  • 10Bhagavan N V,Lai E M,Rios P A,etal. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction[J]. Clin Chem, 2003,49(4) :581-585.

二级参考文献19

  • 1苏建友,鞠少卿,王惠民,王跃国,朱健华,陈莲英,曹金德,倪隽,尚庆毅.白蛋白钴结合试验测定缺血修饰白蛋白[J].中国交通医学杂志,2005,19(3):210-211. 被引量：23
  • 2Bar-Or D,Lau E,Rao N,et al.Reduction in cobalt binding capacity of human albumin with myocardial ischemica[J].Ann Emerg Med,1999,34(4Suppl):S56
  • 3Bar-Or D,Lau E,Winkler JV.A novel assay for cobalt-albumin binding and itspotential as a marker for myocardial ischemia-a preliminary report[J].J Emerg Med,2000,19(4):311
  • 4Montagnana M,Lippi G,Guidi GC.New perspectives in the diagnostic approach to acute coronary syndrome[J].Recenti Prog Med,2005,96(4):171
  • 5Bhagavan NV,Lai EM,Rois PA,et al.Evaluation of Human serum albumin cobalt binding assay for the assessment of myocardialischemia and myocardial infarction[J].Clin Chem,2003,49(4):581
  • 6Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med,2000,19(4) :311-315.
  • 7Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem,2003, 49(4) :581-585.
  • 8Roy D, Quiles J, Gaze DC,et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart, 2006,92(1) : 113-114.
  • 9Peacock F, Morris DL, Anwaruddin S, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J,2006,152(2) :253-262.
  • 10Abadie JM, Blassingame CL, Bankson DD. Albumin cobalt binding assay to rule out acute coronary syndrome. Arm Clin Lab Sci, 2005,35(1 ) :66-72.

共引文献25

药学服务与研究
2008年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部